G. Ross
- Oncology top 2%
- Lung Cancer Research Studies 16
- HER2/EGFR in Cancer Research 14
- Cancer Treatment and Pharmacology 7
- Cancer Research top 5%
- Breast Cancer Treatment Studies 6
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 9
- Obstetrics and Gynecology top 5%
-
- Cancer therapeutics and mechanisms 15
-
- Intraperitoneal and Appendiceal Malignancies 6
-
- Neuroendocrine Tumor Research Advances 5
G. Ross
48 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 1.4k
- Cancer Research 567
- Reproductive Medicine 255
- Radiology, Nuclear Medicine and Imaging 539
- Obstetrics and Gynecology 106
Countries citing papers authored by G. Ross
This map shows the geographic impact of G. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ross more than expected).
Fields of papers citing papers by G. Ross
This network shows the impact of papers produced by G. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ross. The network helps show where G. Ross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Phase I dose-escalation study of ATR inhibitor monotherapy with AZD6738 in advanced solid tumors (PATRIOT Part A) | 2017 | 1 |
| 2 | 2013 | 52 | |
| 3 | Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)breakdown → | 2013 | 774 |
| 4 | 2011 | 93 | |
| 5 | 2011 | 44 | |
| 6 | 2009 | 31 | |
| 7 | 2007 | 49 | |
| 8 | 2006 | 12 | |
| 9 | 2004 | 38 | |
| 10 | 2003 | 86 | |
| 11 | 2002 | 82 | |
| 12 | 2002 | 6 | |
| 13 | 2002 | 9 | |
| 14 | 2001 | 12 | |
| 15 | 2001 | 10 | |
| 16 | 2000 | 4 | |
| 17 | 1997 | 9 | |
| 18 | 1995 | 7 | |
| 19 | 1993 | 34 | |
| 20 | 1993 | 10 |
About G. Ross
G. Ross is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 48 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (16 papers), Cancer therapeutics and mechanisms (15 papers), HER2/EGFR in Cancer Research (14 papers), Ovarian cancer diagnosis and treatment (9 papers), Cancer Treatment and Pharmacology (7 papers), Intraperitoneal and Appendiceal Malignancies (6 papers), Breast Cancer Treatment Studies (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (567 citations) and Reproductive Medicine (255 citations). G. Ross has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Javier Cortés, Andreas Schneeweiß, Virginia McNally, Roberto Hegg, Christoph Tausch, Tamas Hickish, V. Harvey, Alexandru Eniu, Jayantha Ratnayake and Stephen Chia. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, European Journal of Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.